Comparing Tofacitinib vs Zeposia
| Tofacitinib | Zeposia (ozanimod) |
|
|---|
| Tofacitinib | Zeposia (ozanimod) |
|
|---|---|---|
|
Prescription only
Prescribed for Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Ulcerative Colitis. Tofacitinib may also be used for purposes not listed... View more |
Prescription only
Zeposia is an S1P receptor modulator that may be used to treat relapsing forms of multiple sclerosis or ulcerative colitis in adults. It requires a 7-day titration period and reduces lymphocyte... View more |
Related suggestions Ulcerative Colitis
|
| More about Tofacitinib | More about Zeposia (ozanimod) | |
| Ratings & Reviews | ||
|
Tofacitinib has an average rating of 5.7 out of 10 from a total of 176 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 39% reported a negative effect. |
Zeposia has an average rating of 8.8 out of 10 from a total of 8 ratings on Drugs.com. 88% of reviewers reported a positive effect, while 0% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Tofacitinib side effects |
View all Zeposia side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
||
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
|
|
| Brand Names | ||
| Xeljanz, Xeljanz Oral Solution, Xeljanz XR |
N/A |
|
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
3 hours |
264 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 680 drugs are known to interact with Tofacitinib:
|
A total of 942 drugs are known to interact with Zeposia:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
November 06, 2012 |
March 25, 2020 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.